Is OptimizeRx Corp. overvalued?

OptimizeRx Corp. (OPRX) — key valuation metrics and fundamentals.

No verdict

Price

$8.72

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$163.6M

Dividend yield

0.0%

Return on equity

5.5%

Sector

Healthcare

Fair value compares OPRX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks